企業プロフィール
NeuroOne Medical Technologies 株価・ニュース・カタリスト
- ティッカー:
- NMTC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.14 USD (+5.42%)
終値
最終更新: 2026年8月24日
30.7M USD
時価総額
株価変動の要因
As of Aug 24, 2026, NMTC closed up 5.42% at $2.14. No new same-company headline was identified in the current news window.
企業概要
事業概要
NeuroOne Medical Technologies is a medical technology company focused on neurodiagnostic and neurosurgical tools. Its products are aimed at improving procedures and monitoring in the neurology and epilepsy workflow.
所在地とセクター分類
NeuroOne is headquartered in the United States and listed on NASDAQ. It sits in medical devices rather than biotechnology.
ビジネスモデルの特徴
The business depends on device adoption, hospital and physician workflow integration, and the ability to expand product utilization across neurological procedures. Investors watch capital sales, product clearances, and commercial execution.
バイオ業界での位置付け
NeuroOne is part of the neurology-device layer of healthcare, not biotech. Its stock is driven by procedural adoption and product rollout rather than drug catalysts.
今後のカタリスト
- NeuroOne’s catalysts are minimally invasive neurology devices and adoption in epilepsy / neurosurgery workflows. The stock will respond to whether the installed base keeps expanding.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。